Halder acquires DermaZentrum
Strengthening a leading platform in the field of dermatology.
Halder has acquired a majority stake in DermaZentrum (Munich, Germany) as part of an owners buy-out with founder Prof. Dr. Meineke remaining on board as co-shareholder and CEO.
DermaZentrum, founded in 2018, has rapidly emerged to one of the leading dermatology chains in Germany and operates 13 practices today. The company offers state-of-the-art medical and aesthetic dermatology services.
DermaZentrum’s service offering mainly comprises of classical dermatological treatments, allergology, aesthetic medicine and cosmetics for adults as well as for children. The full-service offering is provided for patients regardless of their insurance. With more than 80.000 patient treatments per year, DermaZentrum has emerged to one of the leading providers of medical dermatology and aesthetic dermatology services in Germany.
Future growth potentials arise from Germany’s demographic development with an aging population and an increasing focus on aesthetic appearance. With the support of Halder, DermaZentrum will continue to expand its high-quality service offering and aim to grow its regional footprint. DermaZentrum founder Prof. Dr. Meineke will continue to lead the business as co-shareholder and CEO.
Mathias Fackelmeyer, Managing Partner at Halder, added: “Prof. Dr. Meineke and his team of outstanding medical professionals have impressed us from the beginning. We see great potential to roll out their high level of expertise in conjunction with the proximity to the patient and are looking forward to shaping this expansion together”.
With Halder, we have found a very experienced partner who will accompany and support the successful and rapid growth strategy of DermaZentrum that has been started in recent years.
Prof. Dr Meineke